ABOS
Price
$1.77
Change
-$0.08 (-4.32%)
Updated
Dec 23, 04:59 PM (EDT)
97 days until earnings call
PYXS
Price
$1.68
Change
-$0.02 (-1.18%)
Updated
Dec 23, 04:59 PM (EDT)
87 days until earnings call
Ad is loading...

ABOS vs PYXS

Header iconABOS vs PYXS Comparison
Open Charts ABOS vs PYXSBanner chart's image
Acumen Pharmaceuticals
Price$1.77
Change-$0.08 (-4.32%)
Volume$4.62K
CapitalizationN/A
Pyxis Oncology
Price$1.68
Change-$0.02 (-1.18%)
Volume$19.04K
CapitalizationN/A
ABOS vs PYXS Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. PYXS commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a StrongBuy and PYXS is a Hold.

COMPARISON
Comparison
Dec 24, 2024
Stock price -- (ABOS: $1.77 vs. PYXS: $1.67)
Brand notoriety: ABOS and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 285% vs. PYXS: 46%
Market capitalization -- ABOS: $106.34M vs. PYXS: $99.31M
ABOS [@Biotechnology] is valued at $106.34M. PYXS’s [@Biotechnology] market capitalization is $99.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, PYXS is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while PYXS’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 4 bearish.
  • PYXS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ABOS and PYXS are a good buy in the short-term.

Price Growth

ABOS (@Biotechnology) experienced а -10.15% price change this week, while PYXS (@Biotechnology) price change was -0.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.75%. For the same industry, the average monthly price growth was -2.52%, and the average quarterly price growth was +3.67%.

Reported Earning Dates

ABOS is expected to report earnings on Mar 31, 2025.

PYXS is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-1.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABOS($106M) has a higher market cap than PYXS($99.3M). PYXS YTD gains are higher at: -6.111 vs. ABOS (-53.906). PYXS has higher annual earnings (EBITDA): -64.04M vs. ABOS (-77.89M). ABOS has more cash in the bank: 200M vs. PYXS (145M). PYXS has less debt than ABOS: PYXS (20.5M) vs ABOS (28.5M). PYXS has higher revenues than ABOS: PYXS (16.1M) vs ABOS (0).
ABOSPYXSABOS / PYXS
Capitalization106M99.3M107%
EBITDA-77.89M-64.04M122%
Gain YTD-53.906-6.111882%
P/E RatioN/AN/A-
Revenue016.1M-
Total Cash200M145M138%
Total Debt28.5M20.5M139%
TECHNICAL ANALYSIS
Technical Analysis
ABOSPYXS
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 4 days ago
77%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 4 days ago
70%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VEXTF0.130.01
+5.61%
Vext Science Inc.
DNKEY14.000.26
+1.89%
Danske Bank A/S
ITOCY97.031.07
+1.12%
Itochu Corp.
AZMCF1.15N/A
+0.43%
Arizona Metals Corp.
TLPFY41.91-0.82
-1.92%
Teleperformance

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with INZY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-4.32%
INZY - ABOS
50%
Loosely correlated
+0.67%
MGTX - ABOS
49%
Loosely correlated
-0.98%
BEAM - ABOS
48%
Loosely correlated
-1.07%
AURA - ABOS
48%
Loosely correlated
-0.24%
SNDX - ABOS
47%
Loosely correlated
+1.76%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
+9.74%
KURA - PYXS
44%
Loosely correlated
+0.45%
CTMX - PYXS
39%
Loosely correlated
-0.91%
BEAM - PYXS
36%
Loosely correlated
+8.04%
DNLI - PYXS
35%
Loosely correlated
-0.19%
ABOS - PYXS
34%
Loosely correlated
+2.78%
More